細胞選別磁気ビーズの市場調査レポート

Market Overview

Cell sorting magnetic beads are critical tools in biomedical research and cell therapy, with rapid market growth in recent years. The global magnetic beads market reached USD 3.89 億で 2024 and is projected to exceed USD 16.01 10億まで 2037, growing at a compound annual growth rate (CAGR) の 11.5%. Cell sorting beads account for 10–15% of the total cost in CAR-T cell therapy production. しかし, 以上 95% of the market is dominated by international players like Miltenyi Biotec and Thermo Fisher, while Chinese domestic companies remain in the technological catch-up phase.  

主な用途

CAR-T Cell Therapy: Used for high-purity T-cell isolation, 達成する 99% CD3cell purity post-sorting (例えば, CD3cell ratio reduced from 36.5% に 0.7% in clinical cases).

Immunology Research: Sorting immune cells (B cells, NK cells) via antigen-specific magnetic labeling.

Stem Cell Therapy: Isolation of hematopoietic stem cells and mesenchymal stem cells for regenerative medicine.

In Vitro Diagnostics(IVD): Rapid enrichment of circulating tumor cells (CTCs) or pathogens. Market Drivers  

Growth of Cell Therapy: Expanding CAR-T therapy commercialization drives demand, with magnetic beads constituting 10–15% of production costs.

Precision Medicine: High-purity cell isolation is essential for single-cell sequencing and personalized therapies.

Localization Trends: Chinese companies like GenScript offer GMP-grade CytoSinct™ beads at 20–30% lower prices than imports, supported by policies promoting domestic alternatives. Technology Advancements: Nano-sized beads (50–70 nm) with high antibody conjugation efficiency and superparamagnetic properties are mainstream.

競争環境

国際的なリーダー: Miltenyi Biotec, サーモフィッシャー, and BD control over 90% of the high-end market with end-to-end solutions.

Domestic Players: Companies like GenScript and Beaver Biosciences focus on cost-effective mid-to-low-end markets. GenScript’s beads are used in CAR-T clinical trials.

Technical Challenges: Key barriers include bead size uniformity, antibody conjugation efficiency, and batch consistency. Domestic firms face hurdles in scaling nano-bead production.

今後の展望

The cell sorting magnetic beads market is expected to grow at over 12% CAGR from 2025 に 2030, driven by cell and gene therapy expansion. Chinese companies may achieve over 30% import substitution in 3–5 years, particularly in GMP-grade bead production, supported by policies like the 14th Five-Year Plan for biopharma innovation.  

サプライヤー

上海霊軍生物技術有限公司, 株式会社に設立されました 2016 生体磁性材料と核酸抽出試薬の専門メーカーです.

核酸抽出・精製の経験が豊富です。, タンパク質の精製, 細胞分離, 化学発光, その他の技術分野.

当社の製品はさまざまな分野で広く使用されています, 医療検査など, 遺伝子検査, 大学の研究, 遺伝子育種, 等々. 製品のご提供だけでなくOEMも承ります, ODM, その他のニーズ. 関連するニーズがある場合, お気軽にお問い合わせください .